Nexalin Technology completes Q-Sub meeting with US FDA for Gen-2 SYNC neurostimulation console in Alzheimer’s disease programme: Houston, Texas Friday, December 5, 2025, 16:00 H ...
As prominent artificial intelligence (AI) researchers eye limits to the current phase of the technology, a different approach is gaining attention: using living human brain cells as computational ...
With cold and flu season upon us – and yes, COVID too – tune in to this Community Connection piece featuring St. Luke’s ...